| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 95.766 | 91.535 | 107.040 | 93.340 | 83.803 | 83.536 | 79.494 | 93.182 | 117.633 | 123.078 |
| Total Income - EUR | 95.769 | 91.537 | 107.292 | 93.377 | 83.869 | 83.537 | 79.501 | 93.185 | 118.531 | 123.143 |
| Total Expenses - EUR | 115.553 | 98.331 | 110.505 | 108.424 | 115.879 | 110.482 | 98.760 | 147.562 | 173.379 | 155.979 |
| Gross Profit/Loss - EUR | -19.784 | -6.794 | -3.212 | -15.047 | -32.010 | -26.945 | -19.259 | -54.377 | -54.848 | -32.836 |
| Net Profit/Loss - EUR | -19.784 | -6.794 | -3.212 | -15.047 | -32.010 | -26.945 | -19.259 | -54.377 | -54.848 | -32.836 |
| Employees | 10 | 5 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 |
Check the financial reports for the company - Apoterm Nadlac S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.847 | 3.653 | 2.491 | 1.691 | 919 | 184 | 77 | 63 | 2.587 | 1.790 |
| Current Assets | 25.618 | 29.761 | 26.343 | 34.968 | 27.018 | 38.321 | 38.042 | 127.432 | 61.089 | 57.901 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.756 | 24.463 | 21.703 | 24.028 | 24.111 | 27.746 | 32.516 | 117.812 | 53.493 | 51.750 |
| Cash | 5.862 | 5.299 | 4.640 | 10.940 | 2.907 | 10.575 | 5.526 | 9.620 | 7.597 | 6.151 |
| Shareholders Funds | 6.852 | -11 | -5.715 | -20.711 | -35.567 | -61.838 | -79.726 | 46.136 | -8.851 | -41.638 |
| Social Capital | 93.649 | 92.694 | 91.125 | 89.453 | 104.474 | 102.493 | 100.220 | 255.801 | 323.032 | 321.227 |
| Debts | 24.613 | 33.426 | 34.548 | 57.371 | 63.504 | 100.343 | 117.845 | 81.359 | 72.528 | 101.329 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3530 - 3530" | |||||||||
| CAEN Financial Year |
3530
|
|||||||||
Comments - Apoterm Nadlac S.r.l.